b6lq0aue

Property	Value
?:abstract	Since February 12, 2020, approximately 6.5 million cases of SARS-CoV-2 infection, the cause of coronavirus disease 2019 (COVID-19), and 190,000 SARS-CoV-2-associated deaths have been reported in the United States (1,2). Symptoms associated with SARS-CoV-2 infection are milder in children compared with adults (3). Persons aged <21 years constitute 26% of the U.S. population (4), and this report describes characteristics of U.S. persons in that population who died in association with SARS-CoV-2 infection, as reported by public health jurisdictions. Among 121 SARS-CoV-2-associated deaths reported to CDC among persons aged <21 years in the United States during February 12-July 31, 2020, 63% occurred in males, 10% of decedents were aged <1 year, 20% were aged 1-9 years, 70% were aged 10-20 years, 45% were Hispanic persons, 29% were non-Hispanic Black (Black) persons, and 4% were non-Hispanic American Indian or Alaska Native (AI/AN) persons. Among these 121 decedents, 91 (75%) had an underlying medical condition,* 79 (65%) died after admission to a hospital, and 39 (32%) died at home or in the emergency department (ED).† These data show that nearly three quarters of SARS-CoV-2-associated deaths among infants, children, adolescents, and young adults have occurred in persons aged 10-20 years, with a disproportionate percentage among young adults aged 18-20 years and among Hispanics, Blacks, AI/ANs, and persons with underlying medical conditions. Careful monitoring of SARS-CoV-2 infections, deaths, and other severe outcomes among persons aged <21 years remains particularly important as schools reopen in the United States. Ongoing evaluation of effectiveness of prevention and control strategies will also be important to inform public health guidance for schools and parents and other caregivers.
?:creator	<https://research.tib.eu/covid-19/entity/Bixler%2C_Danae%3B_Miller%2C_Allison_D%3B_Mattison%2C_Claire_P%3B_Taylor%2C_Burnestine%3B_Komatsu%2C_Kenneth%3B_Peterson_Pompa%2C_Xandy%3B_Moon%2C_Steve%3B_Karmarkar%2C_Ellora%3B_Liu%2C_Caterina_Y%3B_Openshaw%2C_John_J%3B_Plotzker%2C_Rosalyn_E%3B_Rosen%2C_Hilary_E%3B_Alden%2C_Nisha%3B_Kawasaki%2C_Breanna%3B_Siniscalchi%2C_Alan%3B_Leapley%2C_Andrea%3B_Drenzek%2C_Cherie%3B_Tobin-D%27Angelo%2C_Melissa%3B_Kauerauf%2C_Judy%3B_Reid%2C_Heather%3B_Hawkins%2C_Eric%3B_White%2C_Kelly%3B_Ahmed%2C_Farah%3B_Hand%2C_Julie%3B_Richardson%2C_Gillian%3B_Sokol%2C_Theresa%3B_Eckel%2C_Seth%3B_Collins%2C_Jim%3B_Holzbauer%2C_Stacy%3B_Kollmann%2C_Leslie%3B_Larson%2C_Linnea%3B_Schiffman%2C_Elizabeth%3B_Kittle%2C_Theresa_S%3B_Hertin%2C_Kimberly%3B_Kraushaar%2C_Vit%3B_Raman%2C_Devin%3B_LeGarde%2C_Victoria%3B_Kinsinger%2C_Lindsey%3B_Peek-Bullock%2C_Melissa%3B_Lifshitz%2C_Jenna%3B_Ojo%2C_Mojisola%3B_Arciuolo%2C_Robert_J%3B_Davidson%2C_Alexander%3B_Huynh%2C_Mary%3B_Lash%2C_Maura_K%3B_Latash%2C_Julia%3B_Lee%2C_Ellen_H%3B_Li%2C_Lan%3B_McGibbon%2C_Emily%3B_McIntosh-Beckles%2C_Natasha%3B_Pouchet%2C_Renee%3B_Ramachandran%2C_Jyotsna_S%3B_Reilly%2C_Kathleen_H%3B_Dufort%2C_Elizabeth%3B_Pulver%2C_Wendy%3B_Zamcheck%2C_Ariela%3B_Wilson%2C_Erica%3B_de_Fijter%2C_Sietske%3B_Naqvi%2C_Ozair%3B_Nalluswami%2C_Kumar%3B_Waller%2C_Kirsten%3B_Bell%2C_Linda_J%3B_Burch%2C_Anna-Kathryn%3B_Radcliffe%2C_Rachel%3B_Fiscus%2C_Michelle_D%3B_Lewis%2C_Adele%3B_Kolsin%2C_Jonathan%3B_Pont%2C_Stephen%3B_Salinas%2C_Andrea%3B_Sanders%2C_Kelsey%3B_Barbeau%2C_Bree%3B_Althomsons%2C_Sandy%3B_Atti%2C_Sukhshant%3B_Brown%2C_Jessica_S%3B_Chang%2C_Arthur%3B_Clarke%2C_Kevin_R%3B_Datta%2C_S_Deblina%3B_Iskander%2C_John%3B_Leitgeb%2C_Brooke%3B_Pindyck%2C_Talia%3B_Priyamvada%2C_Lalita%3B_Reagan-Steiner%2C_Sarah%3B_Scott%2C_Nigel_A%3B_Viens%2C_Laura_J%3B_Zhonga4ec10adfb7e153af1143747d939f1d0>
?:doi	10.15585/mmwr.mm6937e4
?:doi	<https://research.tib.eu/covid-19/entity/10.15585/mmwr.mm6937e4>
?:journal	MMWR._Morbidity_and_mortality_weekly_report
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/32941417>
?:pmid	32941417
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	Medline
?:title	SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-09-18

Property

Value

?:abstract

Since February 12, 2020, approximately 6.5 million cases of SARS-CoV-2 infection, the cause of coronavirus disease 2019 (COVID-19), and 190,000 SARS-CoV-2-associated deaths have been reported in the United States (1,2). Symptoms associated with SARS-CoV-2 infection are milder in children compared with adults (3). Persons aged <21 years constitute 26% of the U.S. population (4), and this report describes characteristics of U.S. persons in that population who died in association with SARS-CoV-2 infection, as reported by public health jurisdictions. Among 121 SARS-CoV-2-associated deaths reported to CDC among persons aged <21 years in the United States during February 12-July 31, 2020, 63% occurred in males, 10% of decedents were aged <1 year, 20% were aged 1-9 years, 70% were aged 10-20 years, 45% were Hispanic persons, 29% were non-Hispanic Black (Black) persons, and 4% were non-Hispanic American Indian or Alaska Native (AI/AN) persons. Among these 121 decedents, 91 (75%) had an underlying medical condition,* 79 (65%) died after admission to a hospital, and 39 (32%) died at home or in the emergency department (ED).† These data show that nearly three quarters of SARS-CoV-2-associated deaths among infants, children, adolescents, and young adults have occurred in persons aged 10-20 years, with a disproportionate percentage among young adults aged 18-20 years and among Hispanics, Blacks, AI/ANs, and persons with underlying medical conditions. Careful monitoring of SARS-CoV-2 infections, deaths, and other severe outcomes among persons aged <21 years remains particularly important as schools reopen in the United States. Ongoing evaluation of effectiveness of prevention and control strategies will also be important to inform public health guidance for schools and parents and other caregivers.

?:creator